Eosinophilia and first-line coagulation testing

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 1, 2009, Pages 90-93

  Lippi, Giuseppe ^a   Montagnana, Martina ^a   Salvagno, Gian Luca ^a   Franchini, Massimo ^b   Targher, Giovanni ^a   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Coagulation testing; Eosinophil; Eosinophilia; Fibrinogen; Platelet

Indexed keywords

FIBRINOGEN;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING TEST; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOSIS;

ADULT; AGED; BLOOD COAGULATION TESTS; EOSINOPHILIA; FEMALE; FIBRINOGEN; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 67449100288     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0247-5     Document Type: Article

References (26)

1. Wang JG, Mahmud SA, Thompson JA, Geng JG, Key NS, Slungaard A (2006) The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: A potential mechanism for thrombosis in eosinophilic inflammatory states. Blood 107:558-565
2. Afshar K, Vucinic V, Sharma OP (2007) Eosinophil cell: Pray tell us what you do! Curr Opin Pulm Med 13:414-421
3. Weller PF, Bubley GL (1994) The idiopathic hypereosinophilic syndrome. Blood 83:2759-2779
4. Roufosse FE, Goldman M, Cogan E (2007) Hypereosinophilic syndromes. Orphanet J Rare Dis 2:37
5. Liao YH, Su YW, Tsay W, Chiu HC (2005) Association of cutaneous necrotizing eosinophilic vasculitis and deep vein thrombosis in hypereosinophilic syndrome. Arch Dermatol 141:1051-1053
6. Liapis H, Ho AK, Brown D, Mindel G, Gleich G (2005) Thrombotic microangiopathy associated with the hypereosinophilic syndrome. Kidney Int 67:1806-1811
7. Fitzpatrick JE, Johnson C, Simon P, Owenby J (1987) Cutaneous microthrombi: A histologic clue to the diagnosis of hypereosinophilic syndrome. Am J Dermatopathol 9:419-422
8. Kojima K, Sasaki T (1995) Veno-occlusive disease in hypereosinophilic syndrome. Intern Med 34:1194-1197
9. Schulman H, Hertzog L, Zirkin H, Hertzanu Y (1999) Cerebral sinovenous thrombosis in the idiopathic hypereosinophilic syndrome in childhood. Pediatr Radiol 29:595-597
10. Valente O, Scarpinella-Bueno MA (1994) Deep venous thrombosis in hypereosinophilic syndrome. Am Fam Physician 50:921-922
11. Monterrubio Villar J, Córdoba López A, Macayo Sánchez AJ (2006) Idiopathic eosinophilia associated with portal vein and massive thrombosis: Successful thrombolysis with streptokinase. Med Sci Monit 12:CS53-56
12. Mukai HY, Ninomiya H, Mitsuhashi S, Hasegawa Y, Nagasawa T, Abe T (1996) Thromboembolism in a patient with transient eosinophilia. Ann Hematol 72:93-95
13. Butchart EG, Ionescu A, Payne N, Giddings J, Grunkemeier GL, Fraser AG (2003) A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 108(Suppl 1):II68-74
14. Aderka D, Brown A, Zelikovski A, Pinkhas J (1986) Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer. Cancer 57:1846-1849
15. Wasserman SI, Goetzl EJ, Ellman L, Austen KF (1974) Tumor-associated eosinophilotactic factor. N Engl J Med 290:420-424
16. Lippi G, Franchini M, Guidi GC (2007) Diagnostic approach to inherited bleeding disorders. Clin Chem Lab Med 45:2-12
17. Slungaard A, Vercellotti GM, Walker G, Nelson RD, Jacob HS (1990) Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med 171:2025-2041
18. Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, Albrecht S, Lohse P, Patel KD, Engelmann B (2007) Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 109:995-1002
19. Wassom DL, Loegering DA, Solley GO, Moore SB, Schooley RT, Fauci AS, Gleich GJ (1981) Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest 67:651-661
20. Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS (1993) Eosinophil cationic granule proteins impair thrombomodulin function: A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest 91:1721-1730
21. Rohrbach MS, Wheatley CL, Slifman NR, Slifman NR, Gleich GJ (1990) Activation of platelets by eosinophil granule proteins. J Exp Med 172:1271-1274
22. Gauchat JF, Henchoz S, Fattah D, Mazzei G, Aubry JP, Jomotte T, Dash L, Page K, Solari R, Aldebert D et al (1995) CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 25:863-865
23. Santilli F, Basili S, Ferroni P, Davì G (2007) CD40/CD40L system and vascular disease. Intern Emerg Med 2:256-268
24. Sade K, Mysels A, Levo Y, Kivity S (2007) Eosinophilia: A study of 100 hospitalized patients. Eur J Intern Med 18:196-201
25. Lord ST (2007) Fibrinogen and fibrin: Scaffold proteins in hemostasis. Curr Opin Hematol 14:236-241
26. Vannucchi AM, Barbui T (2007) Thrombocytosis and thrombosis. Hematology Am Soc Hematol Educ Program 2007:363-370